Other OTC - Delayed Quote • USD
Eloxx Pharmaceuticals, Inc. (ELOX)
At close: April 25 at 2:26 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -1.22 | 0 | -7.45 | -0.71 |
| Low Estimate | -1.22 | 0 | -7.45 | -0.71 |
| High Estimate | -1.22 | 0 | -7.45 | -0.71 |
| Year Ago EPS | -2.92 | -2.88 | -16.65 | -7.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -2.97 | -2.55 | -1.54 | -1.97 |
| EPS Actual | -2.92 | -2.88 | -1.96 | -1.31 |
| Difference | 0.05 | -0.33 | -0.42 | 0.66 |
| Surprise % | 1.70% | -12.90% | -27.30% | 33.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -1.22 | 0 | -7.45 | -0.71 |
| 7 Days Ago | -1.22 | 0 | -7.45 | -0.71 |
| 30 Days Ago | -1.22 | 0 | -7.45 | -0.71 |
| 60 Days Ago | -1.22 | 0 | -7.45 | -0.71 |
| 90 Days Ago | -1.22 | 0 | -7.45 | -0.71 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ELOX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 58.20% | -- | -- | 2.60% |
| Next Qtr. | -- | -- | -- | 13.40% |
| Current Year | 55.30% | -- | -- | 5.20% |
| Next Year | 90.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 7/11/2023 |
| Reiterates | Oppenheimer: Outperform | 4/6/2023 |
Related Tickers
LEXXW Lexaria Bioscience Corp.
0.7100
-2.74%
ZIVO ZIVO Bioscience, Inc.
8.00
0.00%
CMMB Chemomab Therapeutics Ltd.
0.6590
-1.64%
CWBR CohBar, Inc.
0.8000
0.00%
VRPX Virpax Pharmaceuticals, Inc.
2.9184
-5.55%
NBSE NeuBase Therapeutics, Inc.
0.4420
+4.99%
EVLO Evelo Biosciences, Inc.
0.0457
+3.39%
TVGNW Tevogen Bio Holdings Inc.
0.0550
0.00%
XBIOW Xenetic Biosciences, Inc.
7.46
-17.11%
SABSW SAB Biotherapeutics, Inc.
0.0300
0.00%